Q2 2019 13F Holders as of 30 Jun 2019
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
45,101,565
-
Total 13F shares
-
10,972,436
-
Share change
-
+2,510,918
-
Total reported value
-
$250,918,214
-
Price per share
-
$22.87
-
Number of holders
-
59
-
Value change
-
+$54,344,617
-
Number of buys
-
45
-
Number of sells
-
11
Institutional Holders of Y-mAbs Therapeutics, Inc. - Common Stock, $0.0001 par value per share (YMAB) as of Q2 2019
As of 30 Jun 2019,
Y-mAbs Therapeutics, Inc. - Common Stock, $0.0001 par value per share (YMAB) was held by
59 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
10,972,436 shares.
The largest 10 holders included
Sofinnova Investments, Inc., FMR LLC, BlackRock Inc., Cormorant Asset Management, LP, PRICE T ROWE ASSOCIATES INC /MD/, ALLIANCEBERNSTEIN L.P., VANGUARD GROUP INC, MILLENNIUM MANAGEMENT LLC, Artal Group S.A., and STATE STREET CORP.
This page lists
59
institutional shareholders reporting positions in this security
for the Q2 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.